Park Ha Biological Technology is trading 10.99% down at $3.16 after August 12's securities class-action reminder reiterated the September 28 lead-plaintiff deadline.

  • The lawsuit alleges misleading disclosures, social-media misinformation, impersonated financial professionals, and artificial trading activity; the reminder followed several investor-law-firm notices concerning the pending case and likely added pressure during the August 12 session.
  • Indexes rose as July CPI met expectations, contrasting with today's reversal after an 875.46% August 6 gain amid extreme volatility.